NEO6860, a TRPV1 Antagonist, First in Human Study

Clinical trial NCT02337543 · COMPLETED

Trial details

NCT number: NCT02337543
Sponsor: Neomed Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoarthritis, Knee

Start date: 2015-01-01
Primary completion: 2015-07-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.